Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity

The safety and feasibility of dendritic cell (DC)-based immunotherapies in cancer management have been well documented after more than twenty-five years of experimentation, and, by now, undeniably accepted. On the other hand, it is equally evident that DC-based vaccination as monotherapy did not ach...

Full description

Saved in:
Bibliographic Details
Main Authors: María Julia Lamberti (Author), Annunziata Nigro (Author), Fátima María Mentucci (Author), Natalia Belén Rumie Vittar (Author), Vincenzo Casolaro (Author), Jessica Dal Col (Author)
Format: Book
Published: MDPI AG, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!